BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37872123)

  • 1. Updates on grading mesothelioma.
    Schulte JJ; Husain AN
    Histopathology; 2024 Jan; 84(1):153-162. PubMed ID: 37872123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study.
    Rosen LE; Karrison T; Ananthanarayanan V; Gallan AJ; Adusumilli PS; Alchami FS; Attanoos R; Brcic L; Butnor KJ; Galateau-Sallé F; Hiroshima K; Kadota K; Klampatsa A; Stang NL; Lindenmann J; Litzky LA; Marchevsky A; Medeiros F; Montero MA; Moore DA; Nabeshima K; Pavlisko EN; Roggli VL; Sauter JL; Sharma A; Sheaff M; Travis WD; Vigneswaran WT; Vrugt B; Walts AE; Tjota MY; Krausz T; Husain AN
    Mod Pathol; 2018 Apr; 31(4):598-606. PubMed ID: 29327706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear grading, BAP1, mesothelin and PD-L1 expression in malignant pleural mesothelioma: prognostic implications.
    Forest F; Patoir A; Dal Col P; Sulaiman A; Camy F; Laville D; Bayle-Bleuez S; Fournel P; Habougit C
    Pathology; 2018 Oct; 50(6):635-641. PubMed ID: 30145072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report.
    Pezzuto F; Vimercati L; Fortarezza F; Marzullo A; Pennella A; Cavone D; Punzi A; Caporusso C; d'Amati A; Lettini T; Serio G
    Diagn Pathol; 2021 Jul; 16(1):64. PubMed ID: 34294087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Critical Assessment of Current Grading Schemes for Diffuse Pleural Mesothelioma With a Proposal for a Novel Mesothelioma Weighted Grading Scheme (MWGS).
    Fuchs TL; Chou A; Aksoy Y; Mahjoub M; Sheen A; Sioson L; Ahadi M; Gill AJ
    Am J Surg Pathol; 2022 Jun; 46(6):774-785. PubMed ID: 34907994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Nuclear Grading System in Epithelioid Malignant Pleural Mesothelioma in Biopsy-heavy Setting: An External Validation Study of 563 Cases.
    Zhang YZ; Brambilla C; Molyneaux PL; Rice A; Robertus JL; Jordan S; Lim E; Lang-Lazdunski L; Begum S; Dusmet M; Anikin V; Beddow E; Finch J; Asadi N; Popat S; Cookson WOC; Moffatt MF; Nicholson AG
    Am J Surg Pathol; 2020 Mar; 44(3):347-356. PubMed ID: 32045387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytology of malignant pleural mesothelioma: Diagnostic criteria, WHO classification updates, and immunohistochemical staining markers diagnostic value.
    Shaker N; Wu D; Abid AM
    Diagn Cytopathol; 2022 Nov; 50(11):532-537. PubMed ID: 36069384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's new in mesothelioma.
    Ascoli V; Murer B; Nottegar A; Luchini C; Carella R; Calabrese F; Lunardi F; Cozzi I; Righi L
    Pathologica; 2018 Mar; 110(1):12-28. PubMed ID: 30259910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting.
    Li Y; Salama AM; Baine MK; Bodd FM; Offin MD; Rekhtman N; Zauderer MG; Travis WD; Adusumilli PS; Sauter JL
    Cancer Cytopathol; 2023 Aug; 131(8):495-506. PubMed ID: 37127928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathologic features predict survival in diffuse pleural malignant mesothelioma on pleural biopsies.
    Habougit C; Trombert-Paviot B; Karpathiou G; Casteillo F; Bayle-Bleuez S; Fournel P; Vergnon JM; Tiffet O; Péoc'h M; Forest F
    Virchows Arch; 2017 Jun; 470(6):639-646. PubMed ID: 28349237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined grade and nuclear grade are prognosis predictors of epithelioid malignant peritoneal mesothelioma: a multi-institutional retrospective study.
    Benzerdjeb N; Dartigues P; Kepenekian V; Valmary-Degano S; Mery E; Averous G; Chevallier A; Laverriere MH; Villa I; Sallé FG; Villeneuve L; Glehen O; Isaac S; Hommell-Fontaine J;
    Virchows Arch; 2021 Nov; 479(5):927-936. PubMed ID: 34169365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases.
    Chapel DB; Schulte JJ; Absenger G; Attanoos R; Brcic L; Butnor KJ; Chirieac L; Churg A; Galateau-Sallé F; Hiroshima K; Hung YP; Kindler H; Krausz T; Marchevsky A; Mino-Kenudson M; Mueller J; Nabeshima K; Turaga K; Walts AE; Husain AN
    Mod Pathol; 2021 Feb; 34(2):380-395. PubMed ID: 33060816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Updates in the pathological diagnosis of Pleural Malignant Mesothelioma in the WHO classification of thoracic tumors (5(th) edition)].
    Piao ZH; Zhou XC; Zhang X
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Dec; 40(12):956-960. PubMed ID: 36646495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group.
    Chapel DB; Churg A; Santoni-Rugiu E; Tsujimura T; Hiroshima K; Husain AN
    Lung Cancer; 2019 Jan; 127():69-75. PubMed ID: 30642555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers and prognostic factors for malignant pleural mesothelioma.
    Vigneri P; Martorana F; Manzella L; Stella S
    Future Oncol; 2015; 11(24 Suppl):29-33. PubMed ID: 26638920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological features of epithelioid malignant pleural mesotheliomas in patients with extended survival.
    Paajanen J; Laaksonen S; Kettunen E; Ilonen I; Vehmas T; Salo J; Räsänen J; Sutinen E; Ollila H; Mäyränpää MI; Myllärniemi M; Wolff H
    Hum Pathol; 2020 Apr; 98():110-119. PubMed ID: 32142836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological typing in diffuse malignant epithelioid mesothelioma: implication for prognosis and molecular basis.
    Forest F; Laville D; Habougit C; Corbasson M; Bayle-Bleuez S; Tissot C; Fournel P; Tiffet O; Péoc'h M
    Pathology; 2021 Oct; 53(6):728-734. PubMed ID: 33965253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma.
    Kadota K; Suzuki K; Colovos C; Sima CS; Rusch VW; Travis WD; Adusumilli PS
    Mod Pathol; 2012 Feb; 25(2):260-71. PubMed ID: 21983936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma.
    Hirata T; Zheng Q; Chen Z; Kinoshita H; Okamoto J; Kratz J; Li H; Lui N; Do H; Cheng T; Tseng HH; Koizumi K; Shimizu K; Zhou HM; Jablons D; He B
    Oncol Rep; 2015 Apr; 33(4):2052-60. PubMed ID: 25632963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact on survival of nuclear atypia in epithelioid malignant mesothelioma.
    Mlika M; Limam M; Benzarti A; Mezni F
    Adv Respir Med; 2019; 87(2):90-95. PubMed ID: 31038719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.